Breaking news: GlaxoSmithKline will pay $1.65 billion to buy U.S.-based Reliant Pharmaceuticals, a privately held drug maker that specializes in cardiovascular remedies. Reliant recently posted 9-month revenues of $341 million. Release | Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.